Business, Innovation and Value Creation in the Life Science Industry

Dit vak wordt in het Engels aangeboden. Omschrijvingen kunnen daardoor mogelijk alleen in het Engels worden weergegeven.

Doel vak

Business, Innovation and Value Creation in the Life Sciences Industry
(BIV in LSI) aims to meet two distinct teaching and learning goals:
a. To obtain in-depth and comprehensive insight into current business,
innovation and entrepreneurship trends, approaches and state-of-the-art
practice in the LSI through theory, literature and case analysis.
b. To utilize and apply insights and experiences gained under a. in a
personal entrepreneurship case assignment in which each individual
student elects a
target product or service. And develops a business plan for this product
or service according to a
set methodology. Essential parts of this process include: building
strategy, business modeling, transactional
modelling, building a value proposition, assessing investment
requirements, rNPV modelling, leveraging IP, marketing and
commercialization planning.

Inhoud vak

The Life Sciences Industrial landscape is covered in several ways:
1. Understanding the Pharma, Biotech and Health Care sectors and their
primary and secondary drivers, including the role and contribution of
science and technology.
2. Understanding relevant business, value chain and innovation models
that are common in these industries and sectors.
3. Understanding typical product life-cycle dynamics in the Pharma and
Biotech and related Health sectors.
4. Understanding the relative contribution and position of Genomics,
Proteomics and other scientific areas in the future of
Health and Life Sciences
5. Understanding current product categories and future scenarios for
diagnosis, therapy and prevention

In addition to lectures on the above topics, students will be handed
certain texts and articles that illustrate the `State of the Art’ in the
LSI sector from both a product development as well as from a business
development standpoint. As a result the student will get insight into
the business decisions and dynamics that drive
bio-scientific research from product inception through to development
and product commercialization. The course thus aims to provide an
overview of how life science and business are interwoven in everyday
industrial practice.


A mix of lectures, guest lectures, Pharma sector casework and related
assignments. Individual coaching on the business planning exercise.
Outputs include a report and oral presentations.


In order to receive 6 credits for this course, each student must meet
the following criteria: Case work assignment : will be graded on the
following components according a specific rubric as follows: Definition
including idea generation (5% of final grade), Discovery research (10%
ofg), Construct (10% ofg), Outcomes including Report and
Presentations(75% ofg). Where each component must score 6 or higher.
Absence of active participation in class may result in a lower final

Vereiste voorkennis

Completed Bachelor SBI or comparible


Selected scientific publications
New World Drug Discovery by R Robert M. Rydzewski 2008
Business Model Generation – Osterwalder 2010


Ma SBI, Ma MPA, Ma Oncology

Overige informatie

In case you have any questions about this course, please contact the
coordinator at

Algemene informatie

Vakcode X_432723
Studiepunten 6 EC
Periode P3
Vakniveau 500
Onderwijstaal Engels
Faculteit Faculteit der Bètawetenschappen
Vakcoördinator drs. P. van Hoorn
Examinator drs. P. van Hoorn
Docenten drs. P. van Hoorn
prof. dr. I.J.P. de Esch

Praktische informatie

Voor dit vak moet je zelf intekenen.

Voor dit vak kun je last-minute intekenen.

Werkvormen Hoorcollege

Dit vak is ook toegankelijk als: